These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18332838)

  • 1. Impulse control disorders and pathological gambling in patients with Parkinson disease.
    Stamey W; Jankovic J
    Neurologist; 2008 Mar; 14(2):89-99. PubMed ID: 18332838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study.
    Weintraub D; Sohr M; Potenza MN; Siderowf AD; Stacy M; Voon V; Whetteckey J; Wunderlich GR; Lang AE
    Ann Neurol; 2010 Dec; 68(6):963-8. PubMed ID: 21154480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological gambling caused by drugs used to treat Parkinson disease.
    Dodd ML; Klos KJ; Bower JH; Geda YE; Josephs KA; Ahlskog JE
    Arch Neurol; 2005 Sep; 62(9):1377-81. PubMed ID: 16009751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs can trigger pathological gambling.
    Prescrire Int; 2002 Feb; 11(57):16. PubMed ID: 11985369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is pathological gambling in Parkinson's disease reduced by amantadine?
    Lee JY; Kim HJ; Jeon BS
    Ann Neurol; 2011 Jan; 69(1):213-4; author reply 214-5. PubMed ID: 21280095
    [No Abstract]   [Full Text] [Related]  

  • 6. Internet gambling and other pathological gambling in Parkinson's disease: a case series.
    Wong SH; Cowen Z; Allen EA; Newman PK
    Mov Disord; 2007 Mar; 22(4):591-3. PubMed ID: 17266073
    [No Abstract]   [Full Text] [Related]  

  • 7. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.
    Weintraub D; Koester J; Potenza MN; Siderowf AD; Stacy M; Voon V; Whetteckey J; Wunderlich GR; Lang AE
    Arch Neurol; 2010 May; 67(5):589-95. PubMed ID: 20457959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.
    Avanzi M; Uber E; Bonfà F
    Neurol Sci; 2004 Jun; 25(2):98-101. PubMed ID: 15221629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs.
    Poletti M; Logi C; Lucetti C; Del Dotto P; Baldacci F; Vergallo A; Ulivi M; Del Sarto S; Rossi G; Ceravolo R; Bonuccelli U
    J Clin Psychopharmacol; 2013 Oct; 33(5):691-4. PubMed ID: 23857310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical hazards of the internet: gambling in Parkinson's disease.
    Larner AJ
    Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457
    [No Abstract]   [Full Text] [Related]  

  • 11. Medication-related impulse control and repetitive behaviors in Parkinson disease.
    Voon V; Fox SH
    Arch Neurol; 2007 Aug; 64(8):1089-96. PubMed ID: 17698698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The link between Parkinson's and...gambling?
    Johns Hopkins Med Lett Health After 50; 2009 Aug; 21(6):6-7. PubMed ID: 19722312
    [No Abstract]   [Full Text] [Related]  

  • 13. Impulse control disorders in Parkinson disease: a multicenter case--control study.
    Voon V; Sohr M; Lang AE; Potenza MN; Siderowf AD; Whetteckey J; Weintraub D; Wunderlich GR; Stacy M
    Ann Neurol; 2011 Jun; 69(6):986-96. PubMed ID: 21416496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset.
    Giladi N; Weitzman N; Schreiber S; Shabtai H; Peretz C
    J Psychopharmacol; 2007 Jul; 21(5):501-6. PubMed ID: 17446202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piribedil and pathological gambling in six parkinsonian patients.
    Micheli FE; Giugni JC; Espinosa ME; Calvo DS; Raina GB
    Arq Neuropsiquiatr; 2015 Feb; 73(2):115-8. PubMed ID: 25742580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological gambling secondary to dopaminergic therapy in Parkinson's disease.
    Drapier D; Drapier S; Sauleau P; Derkinderen P; Damier P; Allain H; Vérin M; Millet B
    Psychiatry Res; 2006 Nov; 144(2-3):241-4. PubMed ID: 17011634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impulse control disorder and piribedil: report of 5 cases.
    Tschopp L; Salazar Z; Gomez Botello MT; Roca CU; Micheli F
    Clin Neuropharmacol; 2010; 33(1):11-3. PubMed ID: 19959959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological gambling in Parkinson disease is reduced by amantadine.
    Thomas A; Bonanni L; Gambi F; Di Iorio A; Onofrj M
    Ann Neurol; 2010 Sep; 68(3):400-4. PubMed ID: 20687121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sociodemographic, neuropsychiatric and cognitive characteristics of pathological gambling and impulse control disorders NOS in Parkinson's disease.
    Pontieri FE; Assogna F; Pellicano C; Cacciari C; Pannunzi S; Morrone A; Danese E; Caltagirone C; Spalletta G
    Eur Neuropsychopharmacol; 2015 Jan; 25(1):69-76. PubMed ID: 25435085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impulse control disorders and Parkinson's disease].
    Burkhard PR; Catalano-Chiuvé S; Gronchi-Perrin A; Berney A; Vingerhoets FJ; Lüscher C
    Rev Med Suisse; 2008 May; 4(156):1145-8, 1150. PubMed ID: 18630168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.